arrow
A

Arthur E. Warrington

Mayo Clinic
H指数:32
被引数:4,776

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Early experience with cerebrospinal fluid cell-free DNA molecular profiling in a neuro-oncology practice

神经肿瘤学实践中脑脊液游离DNA分子分型的初步经验

2026-10-030
OA
Cerebrospinal fluid D-2-hydroxyglutarate for IDH-mutant glioma monitoring

脑脊液D-2-羟基戊二酸盐用于IDH突变型胶质瘤监测

2026-03-090
OA
LONGITUDINAL CEREBROSPINAL FLUID D-2-HYDROXYGLUTARATE FOR DISEASE MONITORING IN PATIENTS WITH IDH-MUTANT GLIOMAS

纵向脑脊液D-2-羟基戊二酸盐在IDH突变型胶质瘤患者疾病监测中的应用

2025-11-010
PRE
A hitchhiker's guide to cerebrospinal fluid biomarkers for neuro-oncology

hitchhiker's guide to cerebrospinal fluid biomarkers for neuro-oncology

2024-12-300
PRE
A field resource for the glioma cerebrospinal fluid proteome: impacts of resection and location on biomarker discovery

胶质瘤脑脊液蛋白质组学的领域资源:切除和位置对生物标志物发现的影响

2024-12-300
PRE
An untapped window of opportunity for glioma: targeting therapy-induced senescence prior to recurrence
2023-11-295
OAAI
Blood-brain barrier disruption defines the extracellular metabolome of live human high-grade gliomas
2023-06-207
OAAI
Cerebrospinal fluid 2-hydroxyglutarate as a monitoring biomarker for IDH-mutant gliomas

脑脊液2-羟基戊二酸作为IDH突变胶质瘤的监测生物标志物

2023-05-118
OAAI
Selective Vulnerability of Senescent Glioblastoma Cells to BCL-XL Inhibition
2022-02-2133
OAAI